Polyethylene glycol plus ascorbic acid for bowel preparation in chronic kidney disease

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The safety of polyethylene glycol plus ascorbic acid has not been fully investigated in patients with renal insufficiency. High-dose ascorbic acid could induce hyperoxaluria, thereby causing tubule-interstitial nephritis and renal failure. This study aims to evaluate the safety and efficacy of polyethylene glycol plus ascorbic acid in patients with chronic kidney disease. We retrospectively reviewed prospectively collected data on colonoscopy in patients with impaired renal function. Patients were divided into 2 groups: 2 L polyethylene glycol plus ascorbic acid (n=61) and 4 L polyethylene glycol (n=80). The safety of the 2 groups was compared by assessing the differences in laboratory findings before and after bowel cleansing. The laboratory findings were not significantly different before and after the administration of 2 L polyethylene glycol plus ascorbic acid or 4 L polyethylene glycol. In both groups, the estimated glomerular filtration rate was not influenced by the administration of the bowel-cleansing agent. Patients' reports on tolerance and acceptability were better in the 2 L polyethylene glycol plus ascorbic acid group than in the 4 L polyethylene glycol group. The 2 L polyethylene glycol plus ascorbic acid solution is a safe choice for bowel preparation before colonoscopy in patients with impaired renal function.

Original languageEnglish
Article numbere4755
JournalMedicine (United States)
Volume95
Issue number36
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Chronic Renal Insufficiency
Ascorbic Acid
Colonoscopy
Safety
Renal Insufficiency
Hyperoxaluria
Kidney
Interstitial Nephritis
Glomerular Filtration Rate
Detergents

Keywords

  • Ascorbic acid
  • Chronic kidney disease
  • Colonoscopy
  • Polyethylene glycol
  • Safety

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{7cad4e2cd0884aa4834c805deb468224,
title = "Polyethylene glycol plus ascorbic acid for bowel preparation in chronic kidney disease",
abstract = "The safety of polyethylene glycol plus ascorbic acid has not been fully investigated in patients with renal insufficiency. High-dose ascorbic acid could induce hyperoxaluria, thereby causing tubule-interstitial nephritis and renal failure. This study aims to evaluate the safety and efficacy of polyethylene glycol plus ascorbic acid in patients with chronic kidney disease. We retrospectively reviewed prospectively collected data on colonoscopy in patients with impaired renal function. Patients were divided into 2 groups: 2 L polyethylene glycol plus ascorbic acid (n=61) and 4 L polyethylene glycol (n=80). The safety of the 2 groups was compared by assessing the differences in laboratory findings before and after bowel cleansing. The laboratory findings were not significantly different before and after the administration of 2 L polyethylene glycol plus ascorbic acid or 4 L polyethylene glycol. In both groups, the estimated glomerular filtration rate was not influenced by the administration of the bowel-cleansing agent. Patients' reports on tolerance and acceptability were better in the 2 L polyethylene glycol plus ascorbic acid group than in the 4 L polyethylene glycol group. The 2 L polyethylene glycol plus ascorbic acid solution is a safe choice for bowel preparation before colonoscopy in patients with impaired renal function.",
keywords = "Ascorbic acid, Chronic kidney disease, Colonoscopy, Polyethylene glycol, Safety",
author = "Lee, {Jae Min} and Bora Keum and Yoo, {In Kyung} and Kim, {Seung Han} and Choi, {Hyuk Soon} and Eun-Sun Kim and Seo, {Yeon Seok} and Jeen, {Yoon Tae} and Hoon-Jai Chun and Lee, {Hong Sik} and Soon-Ho Um and Kim, {Chang Duck} and Myung-Gyu Kim and Jo, {Sang Kyung}",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/MD.0000000000004755",
language = "English",
volume = "95",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "36",

}

TY - JOUR

T1 - Polyethylene glycol plus ascorbic acid for bowel preparation in chronic kidney disease

AU - Lee, Jae Min

AU - Keum, Bora

AU - Yoo, In Kyung

AU - Kim, Seung Han

AU - Choi, Hyuk Soon

AU - Kim, Eun-Sun

AU - Seo, Yeon Seok

AU - Jeen, Yoon Tae

AU - Chun, Hoon-Jai

AU - Lee, Hong Sik

AU - Um, Soon-Ho

AU - Kim, Chang Duck

AU - Kim, Myung-Gyu

AU - Jo, Sang Kyung

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The safety of polyethylene glycol plus ascorbic acid has not been fully investigated in patients with renal insufficiency. High-dose ascorbic acid could induce hyperoxaluria, thereby causing tubule-interstitial nephritis and renal failure. This study aims to evaluate the safety and efficacy of polyethylene glycol plus ascorbic acid in patients with chronic kidney disease. We retrospectively reviewed prospectively collected data on colonoscopy in patients with impaired renal function. Patients were divided into 2 groups: 2 L polyethylene glycol plus ascorbic acid (n=61) and 4 L polyethylene glycol (n=80). The safety of the 2 groups was compared by assessing the differences in laboratory findings before and after bowel cleansing. The laboratory findings were not significantly different before and after the administration of 2 L polyethylene glycol plus ascorbic acid or 4 L polyethylene glycol. In both groups, the estimated glomerular filtration rate was not influenced by the administration of the bowel-cleansing agent. Patients' reports on tolerance and acceptability were better in the 2 L polyethylene glycol plus ascorbic acid group than in the 4 L polyethylene glycol group. The 2 L polyethylene glycol plus ascorbic acid solution is a safe choice for bowel preparation before colonoscopy in patients with impaired renal function.

AB - The safety of polyethylene glycol plus ascorbic acid has not been fully investigated in patients with renal insufficiency. High-dose ascorbic acid could induce hyperoxaluria, thereby causing tubule-interstitial nephritis and renal failure. This study aims to evaluate the safety and efficacy of polyethylene glycol plus ascorbic acid in patients with chronic kidney disease. We retrospectively reviewed prospectively collected data on colonoscopy in patients with impaired renal function. Patients were divided into 2 groups: 2 L polyethylene glycol plus ascorbic acid (n=61) and 4 L polyethylene glycol (n=80). The safety of the 2 groups was compared by assessing the differences in laboratory findings before and after bowel cleansing. The laboratory findings were not significantly different before and after the administration of 2 L polyethylene glycol plus ascorbic acid or 4 L polyethylene glycol. In both groups, the estimated glomerular filtration rate was not influenced by the administration of the bowel-cleansing agent. Patients' reports on tolerance and acceptability were better in the 2 L polyethylene glycol plus ascorbic acid group than in the 4 L polyethylene glycol group. The 2 L polyethylene glycol plus ascorbic acid solution is a safe choice for bowel preparation before colonoscopy in patients with impaired renal function.

KW - Ascorbic acid

KW - Chronic kidney disease

KW - Colonoscopy

KW - Polyethylene glycol

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=84988419073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988419073&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000004755

DO - 10.1097/MD.0000000000004755

M3 - Article

C2 - 27603372

AN - SCOPUS:84988419073

VL - 95

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 36

M1 - e4755

ER -